The Net Margin of Inhibikase Therapeutics Inc (IKT) is -7304.75%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -7304.75% |
2023-12-31 | -7304.75% |
2022-12-31 | -15041.67% |
2021-12-31 | -477.10% |
2020-12-31 | -407.14% |
2019-12-31 | -510.71% |
2018-12-31 | -53.22% |
2017-12-31 | -21.36% |
2016-12-31 | -64.95% |